CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3031% below fair value
$89.79+0.27 (+0.30%)
Close on Nov 12, 2026Market cap $114.84BP/E 10.5Yield 2.96%
Cvs Health cash
Cash and short-term investments held at the end of each period.
Cvs Health's cash was $14.89B at Sep 30, 2026. For fiscal 2025 it was $10.60B, down 6.1% from the year before. Over ten years it grew 14.7% a year on average. The highest annual figure on record is $16.08B in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.60B | -6.1% |
| FY2024 | Dec 31, 2024 | $11.29B | -1.4% |
| FY2023 | Dec 31, 2023 | $11.46B | -28.8% |
| FY2022 | Dec 31, 2022 | $16.08B | +1.7% |
| FY2021 | Dec 31, 2021 | $15.81B | +12.6% |
| FY2020 | Dec 31, 2020 | $14.04B | +30.3% |
| FY2019 | Dec 31, 2019 | $10.78B | +18.8% |
| FY2018 | Dec 31, 2018 | $9.08B | +351.3% |
| FY2017 | Dec 31, 2017 | $2.01B | -44.2% |
| FY2016 | Dec 31, 2016 | $3.61B | +33.8% |
| FY2015 | Dec 31, 2015 | $2.70B | +7.2% |
| FY2014 | Dec 31, 2014 | $2.52B | -39.8% |
| FY2013 | Dec 31, 2013 | $4.18B | +202.7% |
| FY2012 | Dec 31, 2012 | $1.38B | -2.7% |
| FY2011 | Dec 31, 2011 | $1.42B | -0.9% |
| FY2010 | Dec 31, 2010 | $1.43B | +31.2% |
| FY2009 | Dec 31, 2009 | $1.09B | -19.3% |
| FY2008 | Dec 31, 2008 | $1.35B | +28.0% |
| FY2007 | Dec 29, 2007 | $1.06B | +99.2% |
| FY2006 | Dec 30, 2006 | $530.00M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $14.89B | +29.6% |
| Q2 FY2026 | Jun 30, 2026 | $13.96B | -3.1% |
| Q1 FY2026 | Mar 31, 2026 | $11.80B | -8.7% |
| Q4 FY2025 | Dec 31, 2025 | $10.60B | -6.1% |
| Q3 FY2025 | Sep 30, 2025 | $11.49B | +15.5% |
| Q2 FY2025 | Jun 30, 2025 | $14.41B | -13.1% |
| Q1 FY2025 | Mar 31, 2025 | $12.92B | -3.5% |
| Q4 FY2024 | Dec 31, 2024 | $11.29B | -1.4% |
| Q3 FY2024 | Sep 30, 2024 | $9.95B | -39.8% |
| Q2 FY2024 | Jun 30, 2024 | $16.58B | -3.7% |
| Q1 FY2024 | Mar 31, 2024 | $13.40B | -25.8% |
| Q4 FY2023 | Dec 31, 2023 | $11.46B | -28.8% |
| Q3 FY2023 | Sep 30, 2023 | $16.52B | -18.8% |
| Q2 FY2023 | Jun 30, 2023 | $17.21B | +12.2% |
| Q1 FY2023 | Mar 31, 2023 | $18.06B | +24.4% |
| Q4 FY2022 | Dec 31, 2022 | $16.08B | +1.7% |
| Q3 FY2022 | Sep 30, 2022 | $20.36B | +58.5% |
| Q2 FY2022 | Jun 30, 2022 | $15.34B | +51.5% |
| Q1 FY2022 | Mar 31, 2022 | $14.51B | +65.1% |
| Q4 FY2021 | Dec 31, 2021 | $15.81B | +12.6% |
| Q3 FY2021 | Sep 30, 2021 | $12.84B | +3.9% |
| Q2 FY2021 | Jun 30, 2021 | $10.13B | -42.9% |
| Q1 FY2021 | Mar 31, 2021 | $8.79B | -32.2% |
| Q4 FY2020 | Dec 31, 2020 | $14.04B | +30.3% |
| Q3 FY2020 | Sep 30, 2020 | $12.36B | +58.4% |
| Q2 FY2020 | Jun 30, 2020 | $17.74B | +101.6% |
| Q1 FY2020 | Mar 31, 2020 | $12.97B | +50.9% |
| Q4 FY2019 | Dec 31, 2019 | $10.78B | +18.8% |
| Q3 FY2019 | Sep 30, 2019 | $7.80B | -81.4% |
| Q2 FY2019 | Jun 30, 2019 | $8.80B | -80.1% |
| Q1 FY2019 | Mar 31, 2019 | $8.59B | -79.7% |
| Q4 FY2018 | Dec 31, 2018 | $9.08B | +351.3% |
| Q3 FY2018 | Sep 30, 2018 | $41.93B | +1424.8% |
| Q2 FY2018 | Jun 30, 2018 | $44.15B | +1772.5% |
| Q1 FY2018 | Mar 31, 2018 | $42.38B | +1617.3% |
| Q4 FY2017 | Dec 31, 2017 | $2.01B | -44.2% |
| Q3 FY2017 | Sep 30, 2017 | $2.75B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.36B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.47B | – |
| Q4 FY2016 | Dec 31, 2016 | $3.61B | – |
See a number that looks wrong?